Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae. 1980

J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou

Netilmicin was compared with sisomicin, tobramycin and amikacin against 65 recent clinical enterobacterial isolates found to be highly resistant to gentamicin (MIC larger than or equal to 80 microgram/ml). Netilmicin showed a high activity against 20 out of 65 strains tested. Most of the sensitive strains (60%) to netilmicin required a concentration of gentamicin equal or lower than 160 microgram/ml for inhibition. Amikacin proved to be extremely effective in all the organisms tested. Tobramycin was consistently less active than either netilmicin or amikacin and the same was the case with sisomicin. The MIC was determined in both solid and liquid media for 24 strains. Depending upon which aminoglycoside was used, we found that 10-30% of the enterobacteriaceae exhibited a twofold diminution of MIC when tested in broth as compared to agar, while the greater proportion of strains was characterized by a higher MIC tested in broth as compared to agar.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D009428 Netilmicin Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. Certomycin,Netillin,Netilmicin Sulfate,Netrocin,Netromicina,Netromycin,Netromycine,Nétromicine,Sch-20569,Sch 20569,Sch20569
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012853 Sisomicin Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex (GENTAMICINS). Sisomycin,Sissomicin,4,5-Dehydrogentamicin,Antibiotic 6640,Extramycin,Pathomycin,Rickamicin,Sch-13475,Siseptin,Sisomicin Sulfate,Sisomicin Sulfate (2:5) Salt,Sizomycin,4,5 Dehydrogentamicin,Sch 13475,Sch13475
D014031 Tobramycin An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species. Nebramycin Factor 6,Brulamycin,Nebcin,Nebicin,Obracin,Tobracin,Tobramycin Sulfate,Sulfate, Tobramycin

Related Publications

J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
October 1976, Antimicrobial agents and chemotherapy,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
February 1983, Mayo Clinic proceedings,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
October 1987, Mayo Clinic proceedings,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
March 1978, Antimicrobial agents and chemotherapy,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
October 1976, Antimicrobial agents and chemotherapy,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
January 1979, The Journal of antimicrobial chemotherapy,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
August 1980, Antimicrobial agents and chemotherapy,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
January 1980, Arzneimittel-Forschung,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
November 1978, Lijecnicki vjesnik,
J Tselentis, and N J Legakis, and K J Nicolas, and K Melissinos, and J Papavassiliou
January 1977, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!